Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
Rolf P Kreutz,1,2 Jeffrey A Breall,1 Anjan Sinha,1 Elisabeth von der Lohe,1 Richard J Kovacs,1 David A Flockhart,2,† 1Krannert Institute of Cardiology, 2Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA †David A Flockhart passed aw...
Saved in:
Main Authors: | Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/65db2ed8857346b4a69976f42d79a6b3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
by: Mshelbwala FS, et al.
Published: (2020) -
Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
by: Ching Wei Russell Chen, et al.
Published: (2019) -
Clopidogrel-Induced Interstitial Lung Disease: A Case Report
by: An J, et al.
Published: (2021) -
Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
by: Jun Xu, et al.
Published: (2019) -
Clinical investigation of transradial access for emergent percutaneous coronary intervention in patients with acute myocardial infarction
by: Qin X, et al.
Published: (2013)